Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.

Newell ML, Huang S, Fiore S, Thorne C, Mandelbrot L, Sullivan JL, Maupin R, Delke I, Watts DH, Gelber RD, Cunningham CK; PACTG 316 Study Team.

BMC Infect Dis. 2007 Jun 20;7:60.

2.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
3.

Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe.

European Collaborative Study, Boer K, England K, Godfried MH, Thorne C.

HIV Med. 2010 Jul 1;11(6):368-78. doi: 10.1111/j.1468-1293.2009.00800.x. Epub 2010 Jan 4.

4.

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy.

European Collaborative Study.

Clin Infect Dis. 2005 Feb 1;40(3):458-65. Epub 2005 Jan 7.

5.

Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.

Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA.

AIDS. 2008 May 11;22(8):973-81. doi: 10.1097/QAD.0b013e3282f9b67a.

PMID:
18453857
6.

Prevention of mother-to-child transmission of human immunodeficiency virus among pregnant women using injecting drugs in Ukraine, 2000-10.

Thorne C, Semenenko I, Malyuta R; Ukraine European Collaborative Study Group in EuroCoord.

Addiction. 2012 Jan;107(1):118-28. doi: 10.1111/j.1360-0443.2011.03609.x. Epub 2011 Oct 12.

7.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Review.

PMID:
21735394
8.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD003510.

PMID:
17253490
9.

U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.

Mofenson LM; Centers for Disease Control and Prevention, U.S. Public Health Service Task Force.

MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4.

10.

Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1.

Read JS, Newell MK.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005479. Review.

PMID:
16235405
11.

Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.

Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, Faye A, Burgard M, Rouzioux C, Mandelbrot L; ANRS French Perinatal Cohort.

AIDS. 2008 Jan 11;22(2):289-99.

PMID:
18097232
12.

Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010.

Briand N, Jasseron C, Sibiude J, Azria E, Pollet J, Hammou Y, Warszawski J, Mandelbrot L.

Am J Obstet Gynecol. 2013 Oct;209(4):335.e1-335.e12. doi: 10.1016/j.ajog.2013.06.021. Epub 2013 Jun 18.

PMID:
23791563
13.
14.

The impact of race/ethnicity on mother-to-child HIV transmission in the United States in Pediatric AIDS Clinical Trials Group Protocol 316.

Cunningham CK, Balasubramanian R, Delke I, Maupin R, Mofenson L, Dorenbaum A, Sullivan JL, Gonzalez-Garcia A, Thorpe E, Rathore M, Gelber RD.

J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):800-7.

PMID:
15213563
15.

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.

Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, Britto P, Rekacewicz C, Newell ML, Delfraissy JF, Cunningham-Schrader B, Mirochnick M, Sullivan JL; International PACTG 316 Team.

JAMA. 2002 Jul 10;288(2):189-98.

PMID:
12095383
16.

Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery.

Aebi-Popp K, Mulcahy F, Glass TR, Rudin C, Martinez de Tejada B, Bertisch B, Fehr J, Grawe C, Scheibner K, Rickenbach M, Hoesli I, Thorne C; European Collaborative Study in EuroCoord; Swiss Mother & Child HIV Cohort Study.

J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):58-65. doi: 10.1097/QAI.0b013e3182a334e3.

PMID:
23842074
17.

Mother-to-child transmission of HIV: experience at a referral hospital in Saudi Arabia.

Edathodu J, Halim MM, Dahham MB, Alrajhi AA.

Ann Saudi Med. 2010 Jan-Feb;30(1):15-7. doi: 10.4103/0256-4947.59367.

18.

Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study.

Thorne C, Semenenko I, Pilipenko T, Malyuta R; Ukraine European Collaborative Study Group.

BMC Infect Dis. 2009 Apr 7;9:40. doi: 10.1186/1471-2334-9-40.

19.

Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants.

Chiappini E, Galli L, Giaquinto C, Ene L, Goetghebuer T, Judd A, Lisi C, Malyuta R, Noguera-Julian A, Ramos JT, Rojo-Conejo P, Rudin C, Tookey P, de Martino M, Thorne C; European Pregnancy and Paediatric HIV Cohort Collaboration study group in EuroCoord.

AIDS. 2013 Mar 27;27(6):991-1000. doi: 10.1097/QAD.0b013e32835cffb1.

PMID:
23211776
20.

Injecting drug use in pregnant HIV-infected women in Europe.

Thorne C, Newell ML.

Med Wieku Rozwoj. 2006 Oct-Dec;10(4):1005-16.

PMID:
17426368
Items per page

Supplemental Content

Write to the Help Desk